BAXCAUTIOUS

BAX EV/EBITDA Analysis

11.1x

Higher than 24% of Healthcare sector peers

Updated 125h ago·SEC filings & market data

Key Takeaway

At 11.4x, Baxter’s EV/EBITDA means its enterprise value—the total cost to acquire the business—is 11.4 times its annual earnings before interest, taxes, depreciation, and amortization.

Sector Performance

24th percentile

BAX

11.1x

Sector Median

15.7x

Sector Avg

29.2x

Prior Period

11.4x(Aug 2026)

↑ Improving

📊

Deep Analysis

At 11.4x, Baxter’s EV/EBITDA means its enterprise value—the total cost to acquire the business—is 11.4 times its annual earnings before interest, taxes, depreciation, and amortization.

This valuation sits well below the healthcare sector median of 16.1x, placing Baxter in the 24th percentile among peers, so it trades cheaper than most comparable companies. The multiple has been increasing over the last eight quarters, with the most recent sequential change up +2.0% quarter-over-quarter from 11.2x to 11.4x; year-over-year change is N/A, but the deeper trend moved from 9.9x to 10.0x to 11.2x to 11.4x. A low level with a rising trend shows the stock’s relative discount is narrowing, which could signal improved expectations or reduced risk of a bargain but also leaves less room for error. This combination supports the overall CAUTIOUS verdict: the upward path in EV/EBITDA, even from a low base, suggests the pricing advantage is fading. Therefore, the metric directly aligns with caution rather than contradicting it.

Frequently Asked Questions

What does the EV/EBITDA tell investors about BAX?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does BAX's EV/EBITDA compare to its sector?

BAX's EV/EBITDA of 11.1x compares to a Healthcare sector median of 15.7x, placing it in the 24th percentile.

Who are BAX's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: CAH (14.4x), RVTY (17.0x), DGX (14.3x), AMGN (14.0x), ALGN (13.5x).

📚

Learn More About EV/EBITDA

EV/EBITDA Explained: The Valuation Metric Pro Investors Actually Use

Learn what EV/EBITDA is, why it beats P/E for capital-heavy companies, typical sector ranges, and key limitations every serious investor should know.

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.